{"id":9961,"date":"2024-02-11T16:39:23","date_gmt":"2024-02-11T15:39:23","guid":{"rendered":"https:\/\/www.afaf.asso.fr\/?p=9961"},"modified":"2024-02-11T16:41:29","modified_gmt":"2024-02-11T15:41:29","slug":"comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich","status":"publish","type":"post","link":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/","title":{"rendered":"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#8217;omaveloxolone avec les donn\u00e9es de l&#8217;histoire naturelle de l&#8217;ataxie de Friedreich"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Lynch DR, Goldsberry A, Rummey C, Farmer J, Boesch S, Delatycki MB, Giunti P, Hoyle JC, Mariotti C, Mathews KD, Nachbauer W, Perlman S, Subramony SH, Wilmot G, Zesiewicz T, Weissfeld L, Meyer C. <em>Ann Clin Transl Neurol.<\/em>2024 Jan;11(1):4-16.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Date de publication : Janvier 2024<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Article : <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37691319\/\" target=\"_blank\" rel=\"noreferrer noopener\">Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data &#8211; PubMed (nih.gov)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lynch DR, Goldsberry A, Rummey C, Farmer J, Boesch S, Delatycki MB, Giunti P, Hoyle JC, Mariotti C, Mathews KD, Nachbauer W, Perlman S, Subramony SH, Wilmot G, Zesiewicz T, Weissfeld L, Meyer C. Ann Clin Transl Neurol.2024 Jan;11(1):4-16. Date de publication : Janvier 2024 Article : Propensity matched comparison of omaveloxolone treatment to Friedreich [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"ocean_front_end_style_editor":"no","ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"0","ocean_second_sidebar":"0","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"0","ocean_custom_header_template":"0","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"0","ocean_menu_typo_font_family":"0","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"0","ocean_post_oembed":"","ocean_post_self_hosted_media":"","ocean_post_video_embed":"","ocean_link_format":"","ocean_link_format_target":"self","ocean_quote_format":"","ocean_quote_format_link":"post","ocean_gallery_link_images":"on","ocean_gallery_id":[],"footnotes":""},"categories":[42],"tags":[],"class_list":["post-9961","post","type-post","status-publish","format-standard","hentry","category-publications_articles_scientifiques","entry","owp-thumbs-layout-horizontal","owp-btn-normal","owp-tabs-layout-section","has-no-thumbnails"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Comparaison\u00a0 par score de propension du traitement \u00e0 l&#039;omaveloxolone avec les donn\u00e9es de l&#039;histoire naturelle de l&#039;ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#039;omaveloxolone avec les donn\u00e9es de l&#039;histoire naturelle de l&#039;ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich\" \/>\n<meta property=\"og:description\" content=\"Lynch DR, Goldsberry A, Rummey C, Farmer J, Boesch S, Delatycki MB, Giunti P, Hoyle JC, Mariotti C, Mathews KD, Nachbauer W, Perlman S, Subramony SH, Wilmot G, Zesiewicz T, Weissfeld L, Meyer C. Ann Clin Transl Neurol.2024 Jan;11(1):4-16. Date de publication : Janvier 2024 Article : Propensity matched comparison of omaveloxolone treatment to Friedreich [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/\" \/>\n<meta property=\"og:site_name\" content=\"Association Fran\u00e7aise Ataxie de Friedreich\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-11T15:39:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-11T15:41:29+00:00\" \/>\n<meta name=\"author\" content=\"Caroline Gaboriau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline Gaboriau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/\"},\"author\":{\"name\":\"Caroline Gaboriau\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#\\\/schema\\\/person\\\/7366aa03c1779ab28140e42231ed7b28\"},\"headline\":\"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#8217;omaveloxolone avec les donn\u00e9es de l&#8217;histoire naturelle de l&#8217;ataxie de Friedreich\",\"datePublished\":\"2024-02-11T15:39:23+00:00\",\"dateModified\":\"2024-02-11T15:41:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/\"},\"wordCount\":83,\"publisher\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#organization\"},\"articleSection\":[\"Publications scientifiques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/\",\"url\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/\",\"name\":\"Comparaison\u00a0 par score de propension du traitement \u00e0 l'omaveloxolone avec les donn\u00e9es de l'histoire naturelle de l'ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#website\"},\"datePublished\":\"2024-02-11T15:39:23+00:00\",\"dateModified\":\"2024-02-11T15:41:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/2024\\\/02\\\/11\\\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.afaf.asso.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#8217;omaveloxolone avec les donn\u00e9es de l&#8217;histoire naturelle de l&#8217;ataxie de Friedreich\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.afaf.asso.fr\\\/\",\"name\":\"Association Fran\u00e7aise Ataxie de Friedreich\",\"description\":\"Association Fran\u00e7aise de l&#039;Ataxie de Friedreich\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.afaf.asso.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#organization\",\"name\":\"Association Fran\u00e7aise Ataxie de Friedreich\",\"url\":\"https:\\\/\\\/www.afaf.asso.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.afaf.asso.fr\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Logo-vert.png\",\"contentUrl\":\"https:\\\/\\\/www.afaf.asso.fr\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Logo-vert.png\",\"width\":1181,\"height\":709,\"caption\":\"Association Fran\u00e7aise Ataxie de Friedreich\"},\"image\":{\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.afaf.asso.fr\\\/#\\\/schema\\\/person\\\/7366aa03c1779ab28140e42231ed7b28\",\"name\":\"Caroline Gaboriau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g\",\"caption\":\"Caroline Gaboriau\"},\"url\":\"https:\\\/\\\/www.afaf.asso.fr\\\/author\\\/caroline_gaboriau\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comparaison\u00a0 par score de propension du traitement \u00e0 l'omaveloxolone avec les donn\u00e9es de l'histoire naturelle de l'ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/","og_locale":"fr_FR","og_type":"article","og_title":"Comparaison\u00a0 par score de propension du traitement \u00e0 l'omaveloxolone avec les donn\u00e9es de l'histoire naturelle de l'ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich","og_description":"Lynch DR, Goldsberry A, Rummey C, Farmer J, Boesch S, Delatycki MB, Giunti P, Hoyle JC, Mariotti C, Mathews KD, Nachbauer W, Perlman S, Subramony SH, Wilmot G, Zesiewicz T, Weissfeld L, Meyer C. Ann Clin Transl Neurol.2024 Jan;11(1):4-16. Date de publication : Janvier 2024 Article : Propensity matched comparison of omaveloxolone treatment to Friedreich [&hellip;]","og_url":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/","og_site_name":"Association Fran\u00e7aise Ataxie de Friedreich","article_published_time":"2024-02-11T15:39:23+00:00","article_modified_time":"2024-02-11T15:41:29+00:00","author":"Caroline Gaboriau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Caroline Gaboriau","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/#article","isPartOf":{"@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/"},"author":{"name":"Caroline Gaboriau","@id":"https:\/\/www.afaf.asso.fr\/#\/schema\/person\/7366aa03c1779ab28140e42231ed7b28"},"headline":"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#8217;omaveloxolone avec les donn\u00e9es de l&#8217;histoire naturelle de l&#8217;ataxie de Friedreich","datePublished":"2024-02-11T15:39:23+00:00","dateModified":"2024-02-11T15:41:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/"},"wordCount":83,"publisher":{"@id":"https:\/\/www.afaf.asso.fr\/#organization"},"articleSection":["Publications scientifiques"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/","url":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/","name":"Comparaison\u00a0 par score de propension du traitement \u00e0 l'omaveloxolone avec les donn\u00e9es de l'histoire naturelle de l'ataxie de Friedreich - Association Fran\u00e7aise Ataxie de Friedreich","isPartOf":{"@id":"https:\/\/www.afaf.asso.fr\/#website"},"datePublished":"2024-02-11T15:39:23+00:00","dateModified":"2024-02-11T15:41:29+00:00","breadcrumb":{"@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.afaf.asso.fr\/2024\/02\/11\/comparaison-par-score-de-propension-du-traitement-a-lomaveloxolone-avec-les-donnees-de-lhistoire-naturelle-de-lataxie-de-friedreich\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.afaf.asso.fr\/"},{"@type":"ListItem","position":2,"name":"Comparaison\u00a0 par score de propension du traitement \u00e0 l&#8217;omaveloxolone avec les donn\u00e9es de l&#8217;histoire naturelle de l&#8217;ataxie de Friedreich"}]},{"@type":"WebSite","@id":"https:\/\/www.afaf.asso.fr\/#website","url":"https:\/\/www.afaf.asso.fr\/","name":"Association Fran\u00e7aise Ataxie de Friedreich","description":"Association Fran\u00e7aise de l&#039;Ataxie de Friedreich","publisher":{"@id":"https:\/\/www.afaf.asso.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.afaf.asso.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.afaf.asso.fr\/#organization","name":"Association Fran\u00e7aise Ataxie de Friedreich","url":"https:\/\/www.afaf.asso.fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.afaf.asso.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.afaf.asso.fr\/wp-content\/uploads\/2022\/06\/Logo-vert.png","contentUrl":"https:\/\/www.afaf.asso.fr\/wp-content\/uploads\/2022\/06\/Logo-vert.png","width":1181,"height":709,"caption":"Association Fran\u00e7aise Ataxie de Friedreich"},"image":{"@id":"https:\/\/www.afaf.asso.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.afaf.asso.fr\/#\/schema\/person\/7366aa03c1779ab28140e42231ed7b28","name":"Caroline Gaboriau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8dbf8226706683015a2752bfbf4ecf0bea399e33452121cb9c1f4640fbea214f?s=96&d=mm&r=g","caption":"Caroline Gaboriau"},"url":"https:\/\/www.afaf.asso.fr\/author\/caroline_gaboriau\/"}]}},"_links":{"self":[{"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/posts\/9961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/comments?post=9961"}],"version-history":[{"count":0,"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/posts\/9961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/media?parent=9961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/categories?post=9961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.afaf.asso.fr\/api-afaf\/wp\/v2\/tags?post=9961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}